Prophylactic use of low-dose anticoagulation to prevent venous thromboembolism was associated with reduced 60-day mortality in patients hospitalized with COVID-19 in the state of Michigan.
Join us as our faculty review highlights from the conference and discuss optimal management of thromboembolic disease in 2024.
Join us for a symposium on thromboembolic disease designed to encourage the exchange of ideas between leaders in the field and attendees. Click the ‘Notify…
Join us for a symposium on thromboembolic disease designed to encourage the exchange of ideas between leaders in the field and attendees. Click the ‘Notify…
Join us for a symposium on thromboembolic disease designed to encourage the exchange of ideas between leaders in the field and attendees. Click the ‘Notify…
Anticoagulant use has been critical for reducing the risk of stroke in patients with atrial fibrillation. However, currently available agents are often underutilized or utilized…
Anticoagulant use has been critical for reducing the risk of stroke in patients with atrial fibrillation. However, currently available agents are often underutilized or utilized…
A new study suggested indexed left ventricular systolic volume may predict benefit of beta blocker withdrawal in patients with heart failure with preserved ejection fraction.
The quantity of dysfunctional monocytes appears to indicate poor cardiovascular prognosis in patients with type 2 diabetes, data suggested.
An FDA advisory panel voted 13 to 1 that the benefits of Abbott’s first-of-its-kind transcatheter system to treat tricuspid regurgitation outweigh any potential risks.
Experts offered tips on when to deprescribe hypertension medications against a backdrop of new research that is missing from current recommendations.
